In osteoporosis, downregulation of α5β1 impairs osteogenic activity; in osteoarthritis, fibronectin fragments activate chondrocyte α5β1 to induce matrix degradation; and in bone metastasis, tumor-cell overexpression of α5β1 facilitates colonization of the bone microenvironment. Here, FN1 is linked to neoplasm.